SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIomart Regulatory News (IOM)

Share Price Information for Iomart (IOM)

Share Price is delayed by 15 minutes
Get Live Data
17.75    -0.25 (-1.39%)
Bid:
17.70
Ask:
18.05
Spread: 0.35 (1.977%)
Market Cap: £20.16m
IOM Live PriceLast checked at - London Stock Exchange

Intraday Iomart Share Chart

Form 8.3 - IOMART GROUP PLC

12 Sep 2014 13:50

RNS Number : 5590R
FM Capital Partners Ltd
12 September 2014
 



FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the person whose positions/dealings are being disclosed:

FM Capital Partners Ltd

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

IOMART GROUP PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

11th September 2014

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

NO

 

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

Ordinary Shares

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

(2) Derivatives (other than options):

1,744,448

1.70%

(3) Options and agreements to purchase/sell:

 

TOTAL:

1,744,448

1.70%

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Ordinary share

CFD

 

Increasing long

100,000

279p

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

12th September 2014

Contact name:

Jonny Patterson

Telephone number:

0203 130 7132

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETBDGDCCSBBGSD
Date   Source Headline
13th Apr 20264:41 pmRNSHolding(s) in Company
3rd Mar 20269:40 amRNSBLOCK LISTING SIX MONTHLY RETURN
2nd Mar 202612:04 pmRNSTotal Voting Rights and Share Capital
11th Feb 20267:00 amRNSDirectorate Change and Trading Update
5th Dec 20253:50 pmRNSNotification of Major Holdings
2nd Dec 20257:00 amRNSChange of Auditor
28th Nov 20254:01 pmRNSTotal Voting Rights and Share Capital
26th Nov 20257:00 amRNSHalf Yearly Results
20th Nov 20257:00 amRNSNotice of Results
31st Oct 20253:12 pmRNSTotal Voting Rights and Share Capital
30th Oct 20257:00 amRNSH1 Trading Update
27th Oct 20257:00 amRNSGrant of Options to Directors
6th Oct 20252:42 pmRNSDirector Shareholding
3rd Oct 20253:21 pmRNSDirector's Shareholding
1st Oct 20257:00 amRNSTotal Voting Rights and Share Capital
30th Sep 20254:46 pmRNSDirector Shareholding
25th Sep 20253:16 pmRNSResult of Annual General Meeting
2nd Sep 20257:00 amRNSAnnual Report/Financial Statements & Notice of AGM
1st Sep 20257:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
8th Aug 20252:45 pmRNSNotification of Major Holdings
4th Aug 20252:55 pmRNSNotification of Major Holdings
4th Aug 20252:08 pmRNSNotification of Major Holdings
31st Jul 20254:54 pmRNSNotification of Major Holdings
31st Jul 20254:26 pmRNSNotification of Major Holdings
29th Jul 20252:43 pmRNSNotification of Major Holdings
24th Jul 20257:00 amRNSFinal Results
18th Jul 20259:35 amRNSNotice of Results
4th Jul 202510:53 amRNSNotification of Major Holdings
30th Jun 20257:00 amRNSSuccessful Refinancing and Notice of Results
18th Jun 202510:48 amRNSNotification of Major Holdings
2nd Jun 20254:27 pmRNSTotal Voting Rights and Share Capital
30th May 20257:00 amRNSDirectorate Changes
2nd May 20257:00 amRNS-RTransition to a unified single brand: Atech
1st May 20258:58 amRNSTotal Voting Rights and Share Capital
23rd Apr 20257:00 amRNSPre-close Trading Update
13th Mar 20257:00 amRNSNotification of Major Holdings
3rd Mar 20257:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
7th Feb 20257:00 amRNSTrading update
3rd Feb 20257:00 amRNSTotal Voting Rights and Share Capital
10th Jan 20251:29 pmRNSDirector’s Shareholding
3rd Jan 202510:20 amRNSTotal Voting Rights and Share Capital
4th Dec 202412:40 pmRNSDirector’s Shareholding
2nd Dec 20244:07 pmRNSTotal Voting Rights and Share Capital
27th Nov 20247:00 amRNSHalf Yearly Results
12th Nov 20247:00 amRNSNotice of Results
8th Nov 202411:19 amRNSDirector's Shareholding
1st Nov 20247:00 amRNSTotal Voting Rights and Share Capital
18th Oct 202410:26 amRNSNotification of major holdings
3rd Oct 20247:00 amRNSDirector's Shareholding
1st Oct 20247:00 amRNSAcquisition of Atech and H1 trading update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.